![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 03, 2021 12:19:32 PM
Fundamentally flawed USRM has no direction in the arena of stem cells other than they may have done some research back in the day. Maybe the initials should stand for U.S. Regenerative Medicine. They’ve lost their grip on the stem cell market, so they’re throwing in procedures like laser therapy and NAD injections which are not for low, mid or large cap companies.. cause there’s no large market. No plan exists to turn this company a profit and the accountants just keep slapping on that ‘going concern’ in every audit.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM